Sage shares surge as depression drug succeeds in mid-stage trial Ruby Khatun Khatun9 Dec 2017 4:00 AM GMTDrug developer Sage Therapeutics Inc's shares soared as much as 85 percent to a record high on Thursday after its experimental drug to reduce the...